Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
72-80-0
Molecular formula
C10H7Cl2NO
Molecular weight
228.07 g/mol
Drug class
Local anti-infectivehydroxyquinoline antiseptic and fungistat
Mechanism of action
The exact antimicrobial mechanism is not fully established. Its activity is associated with the local anti-infective properties of the 8-hydroxyquinoline class and may involve interactions with microbial metal-dependent enzymes and cellular processes.
Indications / reported uses
Local treatment of selected skin, gastrointestinal and vaginal infections caused by susceptible fungi, protozoa and bacteria, where authorised.
Topical antiseptic or deodorant use in formulations authorised for the intended site.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Chlorquinaldol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Chlorquinaldol Permitted Daily Exposure (PDE) report (the Chlorquinaldol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Chlorquinaldol Occupational Exposure Limit (OEL) report (the Chlorquinaldol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.